Effect of amino acid substitution in New Delhi metallo-β-lactamase on carbapenem susceptibility

MakaleAçık ErişimScopus SJRQ3
  • SDG 3 · Sağlık ve Kaliteli Yaşam

Özet

The aim of this work was investigation of clinically important amino acid substitutions of NDM-1 variants. A blaNDM-1 gene was cloned into expression vector pET100/D-TOPO. The sequence of NDM-1 variants with substituted amino acids was determined by ClustalW program. A pET100/D-TOPO + blaNDM-1 was used to generate the alanine mutations at different positions, such as NDM-2 (P28A), NDM-3 (D95A), NDM-4 (M154A), NDM-5 (V88A), NDM-7 (D130A), and NDM-9 (E152A). The mutant variants were transformed into Escherichia coli DH5α. Changes in the activities of alanine mutation variants were determined by E-test. All samples had 32 μg/ml MIC values against ampicillin. The 28th amino acid mutation sample had the highest MIC value against ceftazidime, whereas decreased MIC value for piperacillin. It was observed that the resistance to imipenem was increased in mutant variants D95A, M154A, D130A, and E152A, comparing with P28A and V88A. It was found that NDM-1 has 0.64 μg/ml and the 130th amino acid mutation sample has 0.75 μg/ml meropenem MIC value.

Anahtar Kelimeler

RDL Kalıcı Bağlantı (PID)
https://rdlopen.rawdatalibrary.net/r/gumushane/11834Resmi atıflarda kullanılan kalıcı adres
DOI
https://doi.org/10.1556/030.65.2018.022Yayıncı resmi DOI adresi
Atıflar
Scopus
5
WoS
5
OpenAlex
6
Her kaynağın kendi saydığı toplam atıf; aktarım ve zenginleştirme sırasında alındı.
Tam Kayıt
AlanDeğerDil
dc.contributor.authorDüzgün, Azer Özad
dc.date.accessioned2026-10-22T10:19:24.755479824Z
dc.date.available2026-10-22T10:19:24.755479824Z
dc.date.issued2018
dc.description.abstractThe aim of this work was investigation of clinically important amino acid substitutions of NDM-1 variants. A blaNDM-1 gene was cloned into expression vector pET100/D-TOPO. The sequence of NDM-1 variants with substituted amino acids was determined by ClustalW program. A pET100/D-TOPO + blaNDM-1 was used to generate the alanine mutations at different positions, such as NDM-2 (P28A), NDM-3 (D95A), NDM-4 (M154A), NDM-5 (V88A), NDM-7 (D130A), and NDM-9 (E152A). The mutant variants were transformed into Escherichia coli DH5α. Changes in the activities of alanine mutation variants were determined by E-test. All samples had 32 μg/ml MIC values against ampicillin. The 28th amino acid mutation sample had the highest MIC value against ceftazidime, whereas decreased MIC value for piperacillin. It was observed that the resistance to imipenem was increased in mutant variants D95A, M154A, D130A, and E152A, comparing with P28A and V88A. It was found that NDM-1 has 0.64 μg/ml and the 130th amino acid mutation sample has 0.75 μg/ml meropenem MIC value.
dc.identifier.doi10.1556/030.65.2018.022
dc.identifier.eissn1588-2640
dc.identifier.endpage333
dc.identifier.issn1217-8950
dc.identifier.issue3
dc.identifier.pmid29651859
dc.identifier.scopus2-s2.0-85051422265
dc.identifier.startpage325
dc.identifier.urihttps://rdlopen.rawdatalibrary.net/r/gumushane/11834
dc.identifier.volume65
dc.identifier.wosWOS:000441080000006
dc.language.isoen
dc.publisherAkademiai Kiado ZRt.
dc.relation.ispartofActa Microbiologica et Immunologica Hungarica
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectE-test
dc.subjectMBL
dc.subjectMutation
dc.subjectNDM-1
dc.subject.classificationImmunology
dc.subject.classificationMicrobiology
dc.subject.otherAmino Acid Substitution
dc.subject.otherAnti-Bacterial Agents
dc.subject.otherBacterial Proteins
dc.subject.otherbeta-Lactamases
dc.subject.otherCarbapenems
dc.subject.otherDrug Resistance, Multiple, Bacterial
dc.subject.otherHumans
dc.subject.otherKlebsiella Infections
dc.subject.otherKlebsiella pneumoniae
dc.subject.otherMicrobial Sensitivity Tests
dc.subject.otheramoxicillin
dc.subject.otherampicillin
dc.subject.othercarbapenem
dc.subject.othercefepime
dc.subject.othercefotaxime
dc.subject.othercefoxitin
dc.subject.otherceftazidime
dc.subject.otherclavulanic acid
dc.subject.otherertapenem
dc.subject.otherimipenem
dc.subject.othermeropenem
dc.subject.othermetallo beta lactamase
dc.subject.othernew delhi metallo beta lactamase
dc.subject.otherpiperacillin
dc.subject.otherpiperacillin plus tazobactam
dc.subject.otherunclassified drug
dc.subject.otherantiinfective agent
dc.subject.otherbacterial protein
dc.subject.otherbeta lactamase
dc.subject.otherbeta-lactamase NDM-1
dc.subject.othercarbapenem derivative
dc.subject.otherallele
dc.subject.otherantibiotic resistance
dc.subject.otherantibiotic sensitivity
dc.subject.otherArticle
dc.subject.otherbacterial gene
dc.subject.otherbacterial genome
dc.subject.otherbioinformatics
dc.subject.othercloning
dc.subject.othercodon
dc.subject.otherDNA sequence
dc.subject.otherepsilometer test
dc.subject.otherEscherichia coli
dc.subject.otherexpression vector
dc.subject.othergene expression
dc.subject.othergenetic variability
dc.subject.otherminimum inhibitory concentration
dc.subject.othernonhuman
dc.subject.othernucleotide sequence
dc.subject.otherplasmid
dc.subject.otherpolymerase chain reaction
dc.subject.othersequence alignment
dc.subject.othersite directed mutagenesis
dc.subject.otherultraviolet radiation
dc.subject.otherdrug effect
dc.subject.otherenzymology
dc.subject.othergenetics
dc.subject.otherhuman
dc.subject.otherKlebsiella infection
dc.subject.othermetabolism
dc.subject.othermicrobial sensitivity test
dc.subject.othermicrobiology
dc.subject.othermultidrug resistance
dc.titleEffect of amino acid substitution in New Delhi metallo-β-lactamase on carbapenem susceptibility
dc.typeArticle
dspace.entity.typePublication
rdl.citation.openalex6
rdl.citation.scopus5
rdl.citation.wos5
rdl.department1 Faculty of Engineering and Natural Sciences, Department of Genetics and Bioengineering, Gümüşhane University , Gümüşhane, Turkey
rdl.oa.statusbronze
rdl.oa.urlhttps://akjournals.com/downloadpdf/journals/030/65/3/article-p325.pdf
rdl.scopus.quartileQ3
rdl.sdgSDG03
rdl.source.indexSCOPUS
rdl.source.indexWOS
rdl.source.indexPUBMED
rdl.wos.indexScience Citation Index Expanded (SCI-EXPANDED)